SB 1128

  • Oklahoma Senate Bill
  • 2017-2018 Regular Session
  • Introduced in Senate Mar 12, 2018
  • Passed Senate Mar 08, 2018
  • Passed House Apr 26, 2018
  • Governor

Public health and safety; providing limits on practitioners when issuing initial prescriptions for opioid drugs; continuous opioid prescription requirements; exceptions. Effective date.

Abstract

Bill Sponsors (2)

Votes


Actions


May 11, 2018

Senate

Vetoed 05/11/2018

May 01, 2018

Senate

Sent to Governor

Senate

HAs adopted

Senate

Enrolled, to House

Senate

Referred for enrollment

Senate

Measure passed: Ayes: 41 Nays: 1

House

Signed, returned to Senate

Apr 27, 2018

Senate

HAs read

House

Engrossed, signed, to Senate

Apr 26, 2018

House

General Order

House

Coauthored by Representative(s) Downing

House

Amended

House

Third Reading, Measure passed: Ayes: 80 Nays: 5

House

Referred for engrossment

Apr 16, 2018

House

Title restored

House

CR; Do Pass, amended by committee substitute Judiciary Committee

Mar 21, 2018

House

Second Reading referred to Judiciary

Mar 12, 2018

Senate

Engrossed to House

House

First Reading

Mar 08, 2018

Senate

Measure passed: Ayes: 38 Nays: 1

Senate

Referred for engrossment

Senate

General Order, Considered

Mar 05, 2018

Senate

Coauthored by Representative Derby (principal House author)

Feb 26, 2018

Senate

Title stricken

Senate

Reported Do Pass as amended Health and Human Services committee; CR filed

Feb 06, 2018

Senate

Second Reading referred to Health and Human Services

Feb 05, 2018

Senate

Authored by Senator Yen

Senate

First Reading

Bill Text

Bill Text Versions Format
Enrolled (final version) PDF
Amended And Engrossed PDF
Engrossed PDF
Floor (Senate) PDF
Floor (House) PDF
House Committee Substitute for Senate Bill PDF
Introduced PDF

Related Documents

Document Format
Senate Committee Report PDF
House Committee Report PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Oklahoma Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.